Accueil
Highlights PDF Imprimer

Tailored antimicrobial resistance programmes to support behavioural change in the Region
25 February 2018 

WHO supports Libya and Tunisia in development of national action plans for antimicrobial resistance
15 February 2018

Launch of World Antibiotic Awareness Week 2017 in the Region
16 November 2017 

Training of WHONET Super Users in the Eastern Mediterranean Region
27 September 2017

Training of national focal points on the global antimicrobial resistance surveillance system (GLASS)
24 September 2017 

The world is running out of antibiotics
20 September 2017

Development of Iraq's national action plan for antimicrobial resistance 
7 September 2017

Launch of WHO, FAO and OIE global tripartite database on country progress on the implementation of the global action plan on antimicrobial resistance
13 June 2017 

WHO publishes list of bacteria for which new antibiotics are urgently needed
27 February 2017

Capacity review for early implementation of antimicrobial resistance surveillance in Jordan
30 January 2017

Pakistan first country to take steps towards early implementation of antimicrobial resistance surveillance system in the Region
23 March 2016 

 
Regional operational framework PDF Imprimer

The "Regional operational framework for implementation of the Global Action Plan on Antimicrobial Resistance" was developed by the WHO Regional Office for the Eastern Mediterranean, in consultation with Member States. It aims to provide countries of the Region with an operational basis for planning and implementing national action plans on antimicrobial resistance. It identifies the steps in preparing national action plans on antimicrobial resistance and provides prioritized interventions and key resources for countries to use in developing their plans.

The framework outlines 5 global strategic objectives:

  • improve awareness and understanding of antimicrobial resistance through effective communication, education and training; strengthen the knowledge and evidence base through surveillance and research;
  • reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimize the use of antimicrobial medicines in human and animal health;
  • develop the economic case for sustainable investment that takes into account the needs of all countries, and
  • increase investment in new medicines, diagnostic tools, vaccines and other interventions.

Regional operational framework for implementation of the WHO Global Action Plan on Antimicrobial Resistance (2016)

National action plans

National planning is important for controlling antimicrobial resistance. Member States of the Region are urged to develop national plans following resolution WHA68.7 on the Global Action Plan for Antimicrobial Resistance.

Resolution WHA68.7. Global action plan for Antimicrobial resistance

Laboratory and surveillance capacity

Surveillance is a core activity that allows for the detection and tracking of antimicrobial-resistant microorganisms, as well as rapid notification of authorities during an outbreak. Surveillance data can also inform authorities on evidence-based standards and regulations, and help health care managers make appropriate decisions.

In the "WHO Worldwide Country Situation Assessment (2015)" approximately 38% of countries in the Region reported having conducted surveillance for resistant bacteria.

Laboratory capacity remains limited; less than half of the countries in the Region have a national reference laboratory and 5 of the countries participated in external quality assessments. None reported having submitted reports on antimicrobial resistance surveillance and none of the countries had prevalence data.

Access to quality assured antimicrobials

Access to quality assured antimicrobials is essential to avoid the further emergence and spread of antibiotic resistance. Poor quality medicines may have incorrect amounts of active ingredients that can lead to suboptimal dosing. Strong national regulations on the production of antimicrobials and the ability of authorities to monitor quality are key to ensuring high quality antimicrobials.

In the WHO situation analysis only 10 countries in the Region had a national regulatory authority of which 7 could enforce standards, and 4 had quality standards. Nine countries had a list of essential medicines.

Counterfeit medicines are also a problem in Region as in other WHO regions, which is linked to weak regulatory authority. Similarly, the ability to obtain antimicrobials from the Internet remains a problem in the Region as elsewhere in the world.

Infection prevention and control programmes

Infection control and hygiene are critical to stopping the spread of resistant infections in health care settings. Without appropriate infection control practices, health care facilities may act as permanent reservoirs of resistance or amplify the transmission of resistant bacteria within facilities and in the community. Sustainable infection control requires ongoing investments in health care infrastructure, staffing and knowledge.

Current strategies for infection prevention and control efforts in the Region are fragmented. Based on worldwide situation analysis, only 5 out of 21 countries in the Region had infection prevention and control strategies, and only 4 reported that an infection prevention and control programme was available in all tertiary hospitals.

Related link

Worldwide country situation analysis: response to antimicrobial resistance (2015)

 
World Antibiotic Awareness Week PDF Imprimer

2020 - United to preserve antimicrobials

Visit the campaign website

2019 - The future of antibiotics depends on us all

Visit the campaign website

2018 - Change Can’t Wait. Our Time with Antibiotics is Running Out

Visit the campaign website

2017 - Seek advice from a qualified health care professional before taking antibiotics

Visit the campaign website

2016 - Antibiotics: handle with care

In 2016, World Antibiotic Awareness Week was held from 14 to 20 November under the slogan "Antibiotics: handle with care". The 2016 campaign aimed to increase awareness of global antibiotic resistance and called on individuals, governments, health workers and the agricultural sector to follow best practices to avoid the further emergence and spread of antibiotic resistance.

Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. This is compromising our ability to treat infectious diseases and undermining many advances in medicine.

Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria.

World Antibiotic Awareness Week is an initiative arising from Objective 1 of the "Global Action Plan on Antimicrobial Resistance" that urged Member States to address antimicrobial resistance by improving awareness and understanding of antimicrobial resistance through effective communication, education and training.

WHO calls on countries of the Region, partners, including United Nations agencies, ministries of health and agriculture, nongovernmental organizations, human and animal health professionals and others to join the campaign and advocate for the proper use of antibiotics. 

World Antibiotic Awareness Week in the Region focuses on the following messages for the general public:

  • Only use antibiotics when prescribed by a certified health professional.
  • Don’t demand antibiotics if your health worker says you don’t need them.
  • Always follow your health workers’ advice when using antibiotics.
  • Never share leftover antibiotics.
  • Prevent infections by regularly washing your hands, avoiding close contact with sick people, practice safer sex and keeping your vaccinations up to date.

Regional campaign materials

More on World Antibiotic Awareness Week

 
Global Action Plan on Antimicrobial Resistance PDF Imprimer

Global_action_plan_coverGlobal Action Plan on Antimicrobial Resistance (2015)Antimicrobial resistance (AMR) is a serious public health problem worldwide. It threatens the very core of modern medicine and the sustainability of an effective, global public health response to the enduring threat from infectious diseases. Systematic misuse and overuse of these drugs in human medicine and food production have put every nation at risk. Few replacement products are in the pipeline. Without harmonized and immediate action on a global scale, the world is heading towards a post-antibiotic era in which common infections could once again kill.

The "Global Action Plan" to tackle the growing problem of resistance to antibiotics and other antimicrobial medicines was endorsed by the World Health Assembly in May 2015 in resolution WHA67.25. The goal of the plan is to ensure continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality assured, used in a responsible way and accessible to all who need them.

The 5 objectives outlined in the "Global Action Plan" are to:

improve awareness and understanding of antimicrobial resistance

strengthen knowledge through surveillance and research

reduce the incidence of infection

optimize the use of antimicrobial agents

ensure sustainable investment in countering antimicrobial resistance.

The "Global Action Plan" provides a framework for developing national action plans, including key actions that the various actors should take within 5–10 years to combat AMR.

Related links

Global Action Plan on Antimicrobial Resistance (2015)

Food and Agriculture Organization of the United Nations

World Organisation for Animal Health

 
Antimicrobial resistance in the Region PDF Imprimer

Introduction

Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others. AMR is a growing global public health problem that threatens the effective treatment of a number of life-threating infections caused by bacteria, parasites, viruses and fungi that makes treatment of patients difficult, costly and even impossible.

AMR results in prolonged illness and increased mortality. The scope of the problem in the Region is not yet well known nor is the impact of AMR on human health, costs for the health care sector or the wider societal impact. 

AMR occurs naturally over time, usually through genetic changes but resistance has been accelerated by the overuse and misuse of antibiotics in humans and animals.

Without effective antimicrobials for prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, diabetes management and major surgery (for example, caesarean sections or hip replacements) become very high risk.

Misuse of antimicrobial medicines

The misuse and overuse of antimicrobial medicines is fueling resistance worldwide and the Eastern Mediterranean Region is no exception. A number of factors are contributing to this, including:

  • poor prescribing practices
  • incorrect choice of medicine 
  • incorrect dosage
  • self-medication practices. 

Misuse is also linked to failure to complete the dosage or taking an antibiotic for longer than has been prescribed.  

Worldwide country situation analysis: response to antimicrobial resistance (2015)

Misuse and overuse of antimicrobial medicines in animal husbandry and agriculture 

Antimicrobial misuse and overuse in animal production for non-therapeutic purposes, such as for prophylaxis, and as growth promoters, reduces the effectiveness of antimicrobial therapies, and excessive use or misuse are recognized as major drivers of AMR. 

More data are needed on antibiotic consumption in food-producing animals worldwide, and on the occurrence of antimicrobial resistance in different countries and various production systems to develop strategies to avoid inappropriate use, and to reduce antibiotic usage in animal husbandry and aquaculture, as well as in humans. 

WHO, the Food and Agriculture Organization of the United Nations (FAO) and the Organisation for Animal Health (OIE) have established a formal tripartite alliance to enhance global coordination and promote intersectoral collaboration between the public health and animal health sectors, as well as in food safety. The FAO/OIE/WHO Tripartite has identified AMR as one of the 3 priority topics for joint action. 

No countries in the Region have ongoing surveillance of antimicrobial resistance in food-producing animals and food or integrated surveillance of antimicrobial resistance in foodborne bacteria. There is a need to build capacities and to encourage countries in the Region to initiate surveillance programmes to gain a better understanding of AMR transmission mechanisms through food chains to humans and its impact on human populations. 

Food and Agriculture Organization of the United Nations 

Organisation for Animal Health

Surveillance

Surveillance plays a key role in the development and implementation of strategies and interventions to limit the emergence and spread of AMR. Accurate and representative information about the extent and impact of the problem is crucial. 

The collection of information on resistance from diseases such as TB, HIV and malaria is relatively advanced in the Region but reliable data on the magnitude of the problem or associated health and socioeconomic impacts is limited. In 2013, WHO initiated the collection of information on national AMR surveillance for 7 common bacterial pathogens, including the health and economic impacts. The review collected data on 7 resistant common bacteria:

  • Esherichia coli
  • Klebsiella pneumniae
  • Staphylococcus aureus
  • Streptococcus pneumoniae
  • Nontyphoidal salmonella
  • Sigella species
  • Neisseria gonorrhoeae.    

Antimicrobial resistance. A global report on surveillance 2014

 


Page 88 sur 93